There are four main types of diabetes: type 1, type 2, gestational diabetes, and a group of less common forms caused by genetic mutations, pancreatic damage, or medications. About 12% of the U.S. population has some form of diabetes, with type 2 accounting for the vast majority of cases. Each type has a different underlying cause, develops differently, and requires its own approach to management.
Type 1 Diabetes
Type 1 diabetes is an autoimmune condition. The immune system attacks and destroys the insulin-producing cells in the pancreas, eventually leaving the body unable to make insulin at all. Without insulin, glucose builds up in the blood instead of entering cells for energy. About 2.1 million people in the United States have diagnosed type 1 diabetes, including roughly 314,000 children and adolescents.
Symptoms tend to appear quickly, over days or weeks, and often include increased thirst, frequent urination, blurred vision, fatigue, and unexplained weight loss. That rapid weight loss is a hallmark that distinguishes type 1 from type 2. Because the body produces little or no insulin, people with type 1 diabetes need insulin replacement (through injections or a pump) for life.
Type 1 can develop at any age, though it’s most commonly diagnosed in children and young adults. A genetic susceptibility plays a role, particularly certain immune-system gene variants that make a person more likely to develop the autoimmune response. Blood tests can detect specific autoantibodies that confirm the diagnosis.
Type 2 Diabetes
Type 2 diabetes is fundamentally different. There’s no autoimmune attack. Instead, the body’s cells gradually become less responsive to insulin, a problem called insulin resistance. In the early stages, the pancreas compensates by pumping out extra insulin to keep blood sugar levels normal. Over time, though, the pancreas can’t keep up, insulin production declines, and blood sugar rises.
This process unfolds slowly, often over years. Many people with type 2 diabetes have no noticeable symptoms at first, or symptoms so mild they go undetected. When they do appear, they mirror the general signs of diabetes: increased thirst, frequent urination, fatigue, slow-healing sores, and recurrent infections like yeast infections or urinary tract infections.
Type 2 is strongly linked to excess body weight, physical inactivity, and family history. Unlike type 1, it doesn’t involve immune-mediated destruction of the pancreas. Treatment ranges from lifestyle changes and oral medications to injectable insulin, depending on how far the condition has progressed.
Gestational Diabetes
Gestational diabetes develops during pregnancy, typically detected in the second or third trimester. Hormonal changes during pregnancy can make the body more resistant to insulin, and in some women, the pancreas can’t produce enough insulin to overcome that resistance.
Screening usually happens between 24 and 28 weeks of pregnancy. The standard approach involves drinking a glucose solution and having blood sugar measured afterward. If the initial screening is elevated, a longer follow-up test confirms the diagnosis using specific blood sugar thresholds at fasting and at one, two, and three hours after drinking the solution.
Gestational diabetes usually resolves after delivery, but it significantly increases the risk of developing type 2 diabetes later in life. It also raises the risk of complications during pregnancy if blood sugar isn’t well controlled, including higher birth weight and delivery complications.
LADA: The “In-Between” Type
Latent autoimmune diabetes in adults (LADA) is sometimes called type 1.5 because it shares features of both major types. Like type 1, it involves an autoimmune attack on insulin-producing cells. Like type 2, it develops in adulthood and progresses slowly rather than appearing suddenly.
People with LADA are often initially misdiagnosed with type 2 diabetes because of their age and gradual onset. The key difference is the presence of autoantibodies in the blood, the same immune markers found in type 1. Over time, someone with LADA will typically need insulin as their pancreas loses more and more of its ability to produce it, while someone with true type 2 diabetes may manage for years with other medications.
MODY: A Genetic Form
Maturity-onset diabetes of the young (MODY) is caused by a single gene mutation passed through families. It accounts for roughly 1% to 5% of all diabetes cases. Unlike type 1, MODY is not autoimmune. Unlike type 2, it isn’t driven by insulin resistance or lifestyle factors.
MODY typically appears in adolescence or early adulthood and runs strongly in families, usually affecting at least two or three generations. Several different gene mutations can cause it, and the specific mutation determines how severe the diabetes is and how it should be treated. Some forms respond well to oral medications, while others need insulin. Genetic testing is the only way to confirm a MODY diagnosis.
Type 3c: Diabetes From Pancreatic Damage
Type 3c diabetes develops when the pancreas is physically damaged by disease or surgery, impairing its ability to produce insulin. The most common cause is chronic pancreatitis, responsible for about 79% of type 3c cases. Pancreatic cancer accounts for roughly 8%, hemochromatosis (iron overload) about 7%, cystic fibrosis about 4%, and surgical removal of part of the pancreas about 2%.
What makes type 3c distinct is that the same pancreatic damage often affects the organ’s ability to produce digestive enzymes, not just insulin. This means people with type 3c may deal with both high blood sugar and difficulty digesting food, particularly fats. Treatment addresses both problems: insulin for blood sugar control and enzyme supplements to aid digestion.
Neonatal Diabetes
Neonatal diabetes is a rare genetic form that appears within the first six months of life. It affects roughly 1 in 90,000 to 260,000 newborns each year. About half of these cases are permanent, while the other half are transient, meaning they resolve but may return later in life.
Permanent neonatal diabetes is caused by mutations in genes involved in insulin production or release. Three genes account for most cases. Identifying the specific mutation matters because some forms of neonatal diabetes respond to oral medications rather than insulin injections, which can significantly simplify treatment for affected children and their families.
Drug-Induced Diabetes
Certain medications can push blood sugar high enough to cause diabetes, particularly in people who already have some degree of insulin resistance. Corticosteroids (used for inflammation, asthma, and autoimmune conditions) are among the most common culprits. They increase insulin resistance, and in some people, this tips the balance into diabetes. The condition may be temporary, resolving when the medication is stopped, or it may unmask a lasting tendency toward diabetes that requires ongoing management.
How Diabetes Is Diagnosed
Regardless of type, the initial diagnosis of diabetes relies on blood sugar measurements. Three main tests are used, and any one of them can confirm the diagnosis:
- A1C test: Measures average blood sugar over the past two to three months. A result of 6.5% or higher indicates diabetes.
- Fasting blood sugar: Taken after at least eight hours without eating. A result of 126 mg/dL or higher indicates diabetes.
- Oral glucose tolerance test: Blood sugar is measured two hours after drinking a glucose solution. A result of 200 mg/dL or higher indicates diabetes.
These tests confirm that diabetes is present but don’t always reveal which type. Distinguishing type 1 from type 2 or LADA typically requires additional testing for autoantibodies. Identifying MODY or neonatal diabetes requires genetic testing. Type 3c is usually diagnosed based on a known history of pancreatic disease combined with new-onset high blood sugar.